Related Experiment Video

Updated: May 25, 2026

Multiomics Analysis of TMEM200A as a Pan-Cancer Biomarker
07:47

Multiomics Analysis of TMEM200A as a Pan-Cancer Biomarker

Published on: September 15, 2023

MiR-135a targets JAK2 and inhibits gastric cancer cell proliferation

Hao Wu1, Min Huang, Peng Cao

  • 1Department of Oncology, the First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.

Cancer Biology & Therapy
|February 8, 2012
PubMed

Insights

MicroRNA-135a (miR-135a) is downregulated in gastric cancer, acting as a tumor suppressor by targeting Janus kinase 2 (JAK2) to inhibit cancer cell growth.

Area of Science:

  • Oncology
  • Molecular Biology
  • Gene Expression Regulation

Background:

  • Gastric cancer pathogenesis involves tumor suppressors and cell cycle factors, but post-transcriptional gene regulation remains poorly understood.
  • MicroRNAs (miRNAs) are key regulators of gene expression, and their roles in gastric cancer are increasingly recognized.
  • Previous studies indicated miR-135a's involvement in other cancers, prompting investigation into its role in gastric carcinogenesis.

Purpose of the Study:

  • To investigate the expression levels of miR-135a in gastric cancer tissues and cell lines.
  • To identify the direct targets of miR-135a in gastric cancer.
  • To elucidate the functional role of miR-135a in regulating gastric cancer cell proliferation and signaling pathways.

Main Methods:

  • Quantitative real-time PCR (qRT-PCR) was used to assess miR-135a expression in patient tissues and cell lines.
  • Bioinformatic analysis and luciferase reporter assays were employed to identify and validate miR-135a targets.
  • Western blotting was used to analyze protein expression levels of key signaling molecules.

Main Results:

  • miR-135a expression was significantly downregulated in 73% of primary gastric cancer tissues and in various gastric cancer cell lines.
  • Janus kinase 2 (JAK2) was identified as a direct target of miR-135a.
  • Overexpression of miR-135a suppressed gastric cancer cell proliferation, colony formation, and reduced the activation of STAT3 signaling by downregulating JAK2, cyclin D1, and Bcl-xL.

Conclusions:

  • miR-135a functions as a tumor suppressor in gastric cancer.
  • The miR-135a/JAK2 axis plays a critical role in regulating gastric cancer cell growth and survival.
  • Targeting miR-135a represents a potential therapeutic strategy for gastric cancer treatment.

More Related Videos

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells09:45

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells

Published on: May 21, 2019

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...